. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
.
published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt
.
advertisement
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.